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SUMMARY
The ability to control human immunodeficiency virus type 1 (HIV-1) infection and progression of the disease is regulated by
host and viral factors. This cross-sectional study describes the socio-demographic and epidemiological characteristics associated
with HIV-1 infection in 1,061 subjects attended in Londrina and region, south of Brazil: 136 healthy individuals (Group 1), 147
HIV-1-exposed but uninfected individuals (Group 2), 161 HIV-1-infected asymptomatic patients (Group 3), and 617 patients with
AIDS (Group 4). Data were obtained by a standardized questionnaire and serological tests. The age of the individuals ranged from
15.1 to 79.5 years, 54.0% and 56.1% of the Groups 3 and 4 patients, respectively, were men. The major features of groups 2, 3, and
4 were a predominance of education level up to secondary school (55.8%, 60.2% and 62.4%, respectively), sexual route of
exposure (88.4%, 87.0% and 82.0%, respectively), heterosexual behavior (91.8%, 75.2% and 83.7%, respectively), and previous
sexually transmitted diseases (20.4%, 32.5%, and 38.1%, respectively). The patients with AIDS showed the highest rates of
seropositivity for syphilis (25.6%), of anti-HCV (22.3%), and anti-HTLV I/II obtained by two serological screening tests (6.2%
and 6.8%, respectively). The results documenting the predominant characteristics for HIV-1 infection among residents of Londrina
and region, could be useful for the improvement of current HIV-1 prevention, monitoring and therapeutic programs targeted at this
population.
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INTRODUCTION
The natural history and pathogenic processes of human
immunodeficiency virus type 1 (HIV-1) infection are complex and
variable, and depend on a multitude of viral and host factors and their
interactions36. HIV-1-infected individuals present different rates of
disease progression24,32,42. In addition, the susceptibility to HIV-1
infection seems to vary widely among individuals and several groups
that are at risk for HIV-1 infection but have not become infected, defined
as exposed but uninfected, have been reported5,17,27,39. The ability to
control the infection and to delay the progression to AIDS or death is
probably regulated by the balance of host and viral factors: genetic
host susceptibility, immunologic host factors such as qualitative
differences in the primary immune response31,32 and virologic factors
such as extent of HIV-1 replication, viral phenotype, and the immune
evasion strategies of HIV-123.
In the HIV/AIDS epidemic, several proven co-factors and additional
factors still under study have been related to how fast or slow a person
progresses along the pathway towards disease. Socio-demographic
characteristics, sexual behaviors, route of infection, and other risk
factors associated with the sexual transmission of HIV-1 such as age
at first intercourse, number of lifetime partners, and sexually transmitted
diseases (STDs) could be some of the determinant host factors for
HIV-1 acquisition and progression of the disease1,2,7. Social features of
the communities have been also related to the vulnerability to HIV-1
infection4,26.
The HIV-1 epidemic is increasing in Brazil, where over 310,310
cases of HIV/AIDS were notified from 1980 to 2003. The municipality
of Londrina ranks second in the number of AIDS cases in the State of
Paraná, southern region of Brazil, with a total of 1,070 cases notified
between 1984 and 200211. The pattern of the HIV/AIDS epidemic in
Brazil is heterogeneous and has changed according to time, geographic
region, and subpopulations affected15. However, few studies have
examined host factors associated with the HIV-1 infection in this
southern Brazilian population. To address this question, the present
cross-sectional study was carried out in order to describe the socio-
demographic and epidemiological characteristics associated with the
HIV-1 infection, and the seropositivity to other infections that share
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the same transmission route with HIV-1, such as syphilis, hepatitis B,
hepatitis C, and human T lymphotropic virus type I and II (HTLV I/II)
infection in a southern Brazilian cohort of healthy individuals, HIV-1-
exposed but uninfected individuals, and HIV-1-infected individuals in
various stages of infection.
MATERIALS AND METHODS
Study subjects: The convenience sample consisted of individuals
consecutively recruited during the period from September 2001 to
December 2003. The healthy individuals were recruited at the Blood
Bank of the University Hospital of Londrina, north of Paraná State,
southern region of Brazil. The HIV-1-exposed but uninfected and HIV-
1-infected individuals were enrolled in various specialized, public, and
nonprofit centers of STDs such as the University Hospital of State
University of Londrina; Outpatient Clinic Hospital of the State
University of Londrina; Integrated Center of Infectious Diseases of
Londrina, and the State Health Services of various cities from the
northern region of Paraná State, Brazil. The protocol was approved by
the institutional Research Ethics Committees of Londrina State
University, the Health State Secretary of Paraná State and the Brazilian
National Program of STDs/AIDS of the Ministry of Health. The
individuals were invited to participate and informed in detail about the
research, and voluntary written consent was obtained from the subjects
enrolled. Socio-demographic and epidemiological data associated with
HIV-1 infection, and the stage of the disease were obtained at the time
of enrollment from September 2001 to December 2003, using a
Brazilian government standardized interview questionnaire. The
economic level was based on the Criteria for Economic Classification
in Brazil8. After the inclusion, blood samples were collected for
serological and immunological assays. A total of 1,061 individuals
were included and divided into four groups.
Group 1: 136 faithful and screened blood donors of the Blood Bank
of the University Hospital of Londrina, who were seronegative for anti-
HIV-1, anti-HTLV I/II, anti-HCV, hepatitis B surface antigen (HBsAg),
antibodies to hepatitis B core antigen (anti-HBcAg), Chagas disease,
and syphilis, and who had normal serum alanine aminotransferase
levels. The individuals were considered to be at low risk for HIV-1
infection according the risk-screening strategies for determining
individual risk for HIV-1 infection16 and were used as healthy control
to compare with other groups according to socio-demographic, sexual
and parenteral exposures. Because they have all been screened and
were negative to the serological tests evaluated in this study, they were
not used to compare the serological results with other groups.
Group 2: 147 HIV-1-exposed but uninfected individuals, with ≥ 2
consecutive determinations of anti-HIV-1 antibodies by immunological
assays. The individuals were considered to be at high risk for infection
due to self-reported sexual behavior, injectable drug use, or both16.
The individuals reported chronic repeated unprotected sexual exposures
to an infected partner, considered highly exposed over time, and/or
reported a repeated sharing of needles and syringes with HIV-1 infected
patients.
Group 3: 161 HIV-1-infected seroprevalent outpatients, without
the symptoms of the disease, and with CD4+ T cell counts ≥ 350 cells/
mm3. At the time of enrollment, 102 subjects were receiving no
antiretroviral therapy, and 59 were on antiretroviral therapy. The
therapeutic schemes used were in accordance with Brazilian
government recommendations12.
Group 4: 617 HIV-1-infected seroprevalent outpatients and
inpatients with the symptoms of the disease and/or CD4 counts < 350
cells/mm3, according to the Brazilian criteria for AIDS definition9. At
the time of enrollment, 128 subjects were receiving no antiretroviral
therapy, and 489 were on antiretroviral therapy. The therapeutic schemes
used were in accordance with Brazilian government recommendations12.
Serological and immunological assays: Peripheral blood samples
without anticoagulant, were collected for the serological tests. The
screening and confirmatory serological tests for anti-HIV-1 were
performed in serum samples according to standard government
procedures10. The screening tests used were the enzyme immunosorbent
assay (ELISA, Murex™ HIV-1.2.0, Murex Biotech Limited, Dartford
Kent England, UK), and the microparticle enzyme-immunoassay
(MEIA, Abbott Axsym™ System, HIV-1/2 gO, Abbott GmbH,
Weisbaden, Delkenheim, Germany). The confirmatory tests used were
indirect immunofluorescence (slides from Fiocruz Institute, Rio de
Janeiro, Brazil) and Western Blot (Genelabs Diagnostics, Singapore).
The serological tests for syphilis used were VDRL (RPR Bras®,
Laborclin, Curitiba, Paraná) and ELISA (ICE Syphilis™ Murex Biotech
Limited, UK). The serological markers for HBsAg, anti-HBc, anti-
HCV antibodies were determined by MEIA (Abbott Axsym™ System,
Abbott Laboratórios, Brazil). The infection with HTLV I/II was
investigated by screening serological tests using two ELISA with
different antigens: one consisting of purified viral lysates of HTVL-I
and HTLV-II with recombinant antigen p21E of HTLV-I (Vironostika
HTLV-I/II, Bio-Meriéux, Brazil), and the other with a synthetic peptide
from the envelope protein of HTLV I/II and a recombinant
transmembrane protein of HTLV-II (Murex HTLV-I+II, Abbott
Laboratórios, Brazil). The results of reactive samples were confirmed
by Western Blot and/or the polymerase chain reaction (PCR), as
described elsewhere35. CD4+ T and CD8+ T cell counts were determined
in peripheral blood samples collected with EDTA anticoagulant and
by flow cytofluorimetry (FACSCount™ Becton, Dickinson and
Company, San Jose, CA, USA). The results were recorded as number
of cells/mm3 and were used as one of the criteria for AIDS definition9.
Statistical analysis: A database consisting of socio-demographic
and epidemiological characteristics was set up using the EPI INFO
software version 6.04d18. Median, mean and percentage were used to
describe the variables. The chi-square and exact Fisher tests were used
to analyze the frequencies of the categorical variables in each group.
Kruskal-Wallis and Dunn’s Tests21 were used to analyze the continuous
variables and to compare the study groups. The statistical programs
used were EPI INFO18 and SAS44. Differences between groups were
considered to be statistically significant when p < 0.05.
RESULTS
Socio-demographic and epidemiological characteristics: Of the
161 HIV-1-infected asymptomatic individuals (Group 3), 142 (88.2%)
were from Londrina municipality, and the other 19 (11.8%) were from
many cities in the north of the State of Paraná, Brazil. Of 617 HIV-1-
infected individuals with AIDS (Group 4), 543 (88.0%) were from
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Londrina municipality, and the other 74 (12.0%) were from many cities
in the north of the State of Paraná, Brazil.
Table 1 shows the socio-demographic characteristics of the 1,061
subjects according to the four groups. Significant differences were
obtained among the four groups when the variables gender, age, marital
status, education and economic levels were analyzed. Of them, 570
(53.7%) were males and 491 (46.3%) were females. The healthy
individuals (Group 1) were predominantly men (57.3%), and the HIV-
1-exposed but uninfected individuals were predominantly women
(59.9%). The majority (54.0% and 56.1%) of the HIV-infected
asymptomatic patients and AIDS cases were men and the male to female
ratio were 1.17 and 1.28, respectively (p = 0.0046). The age of the
enrolled subjects ranged from 15.1 to 79.5 years. The healthy individuals
were younger than the other subjects, with a median age of 27.2 years,
ranging from 18.2-59.8 years. The majority of HIV-1-exposed but
uninfected, HIV-1-infected asymptomatic individuals and AIDS cases
(37.9%, 37.9% and 42.5%, respectively) were 30-39 years old. A total
of 2 (1.2%) among the HIV-1 asymptomatic individuals and a total of
15 (2.5%) among the AIDS cases were 60 years old or older (p <
0.0001). The race did not differ among groups (p = 0.7640), since the
individuals in groups 1, 2, 3, and 4 were predominantly white (72.1%,
67.3%, 65.8%, and 70.5%, respectively). The non-white subjects were
Orientals (n = 6, 0.6%), Blacks (n = 67, 6.3%) and Mulattoes (n = 250,
23.6%). The major features of the HIV-1-exposed but uninfected, HIV-
1-infected asymptomatic individuals and AIDS cases were the
predominance of married subjects (76.9%, 46.6% and 43.6%,
respectively, p < 0.0001), educational level up to eight years of school
(55.8%, 60.2% and 37.0%, respectively, p < 0.0001) and worst
economic conditions (79.8%, 72.7% and 72.8%, respectively, p <
0.0001), with an income between U$146 and U$319. Among the HIV-
1-infected asymptomatic individuals and AIDS cases, 14.3% and
15.2%, respectively, reported an income of up to U$ 71.
As regard the route of HIV-1 infection, the results showed
significant differences (p < 0.0068), as demonstrated in Table 2.
According to the inclusion criteria, the healthy individuals, considered
at low risk for HIV-1 infection, did not report the sexual exposure, and
two individuals reported the occurrence of blood transfusion before
the HIV/AIDS epidemic. All the 147 HIV-1-exposed but uninfected
individuals had been chronically and repeatedly exposed to HIV-1
through unprotected sexual intercourses with HIV-1-infected partners;
four of them also had blood exposure through shared needles and
syringes with HIV-1-infected individuals, and 13 reported the
occurrence of blood transfusion before (n = 5) and after (n = 8) the
HIV/AIDS epidemic. Among the HIV-1-infected asymptomatic
patients, 140 (87.0%) self-reported unprotected sexual intercourse with
HIV-1-infected individuals, 10 (6.2%) sexual and blood contact through
intravenous drugs use (IVDU) or blood transfusion, nine (5.6%)
reported contact with blood through IVDU (n = 7) or blood transfusion
Table 1
Socio-demographic characteristics of healthy individuals, HIV-1 exposed but uninfected individuals, HIV-1 infected asymptomatic patients, and patients with AIDS,
from Londrina and region, south of Brazil, October 2001 to December 2003
Characteristic Group 1 Group 2 Group 3 Group 4 Total
n = 136 n = 147 n = 161 n = 617
Sexa
Male n (%) 78 (57.3) 59 (40.1) 87 (54.0) 346 (56.1) 570 (53.7)
Rate M/F 1.34 0.67 1.17 1.28 1.16
Age (years)b
Range 18.2-59.8 18.1-73.8 § 14.7-70.4 15.1-79.5 § 15.1-79.5
Median (Mean) 27.2 (30.0) 36.5 (37.3) 32.3 (33.7) 36.5 (37.4) 35.1-35.9
Racec
White n (%) 98 (72.1) 99 (67.3) 106 (65.8) 435 (70.5) 738 (69.6)
Non white§§ n (%) 38 (27.9) 48 (32.7) 55 (34.2) 182 (29.5) 323 (30.4)
Marital statusd
Never or past married 73 (53.7) 34 (23.1) 86 (53.8) 348 (56.4) 541 (51.0)
Now married 63 (46.3) 113 (76.9) 75 (46.6) 269 (43.6) 520 (49.0)
Educatione
Illiterate 3 (2.2) 5 (3.4) 2 (1.2) 28 (4.5) 38 (3.6)
1st - 8th grade 44 (32.4) 82 (55.8) 97 (60.2) 385 (62.4) 608 (53.7)
Secondary/Higher 89 (65.4) 60 (40.8) 62 (38.6) 204 (33.1) 415 (39.1)
Economic levelf
A 13 (9.5) 2 (1.4) 2 (1.2) 12 (1.9) 29 (2.73)
B 40 (29.4) 21 (14.3) 19 (11.8) 62 (10.1) 142 (13.4)
C 46 (33.8) 61 (41.5) 60 (37.3) 192 (31.1) 359 (33.8)
D 37 (27.2) 57 (38.3) 57 (35.4) 257 (41.7) 408 (38.5)
E 0 (0) 6 (4.1) 23 (14.3) 94 (15.2) 123 (11.6)
Group 1: 136 healthy individuals; Group 2: 147 HIV-1 exposed but uninfected individuals; Group 3: 161 HIV-1-infected asymptomatic patients with CD4 T cell counts
≥ 350 cells/mm3; Group 4: 617 HIV-1 infected patients with symptoms of the disease and/or CD4 T cell counts < 350 cells/mm3; a Chi-square test: χ2: 13.0186, p =
0.0046; b Kruskal-Wallis Test: p < 0.0001. § The groups did not differ statistically (Dunn Test, p = 0.4822); c Chi-square test: χ2: 5.76, p = 0.7640. §§The non-white race
individuals included were Orientals (n = 6), Blacks (n = 67), and Mulattoes (n = 250); d Marital status: never married included single (n = 380); past married included
divorced (n = 81), and widowed (n = 80). Chi-square test: χ2: 53.66; p < 0.0001; e: Chi-square test: χ2: 52.64; p < 0.0001; f: Chi-square test: χ2: 120.40; p < 0.0001.
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(n = 2), and two (1.2%) reported an accident with blood. Among the
AIDS cases, the sexual route was predominant, reported by 506 (82.0%)
of patients; 36 (5.8%) reported sexual and blood contact through IVDU,
blood transfusion or an accident with blood, and 68 (11.0%) had contact
with blood through IVDU, blood transfusion or an accident with blood.
Other routes of infections reported were work accident (n = 1), vertical
transmission (n = 2), tattoo (n = 3), and unknown (n = 1). Overall, the
IVDU was reported by three (2.0%), 17 (10.6%) and 85 (13.8%) of the
HIV-1-exposed but uninfected, HIV-1-infected asymptomatic and AIDS
patients, respectively (p = 0.514). A history of blood or hemocomponent
transfusion was reported by 13 (8.8%), five (3.1%) and 29 (4.7%) of
the HIV-1-exposed but uninfected, HIV-1-infected asymptomatic and
AIDS patients, respectively (p = 0.020). As regard the sexual behavior,
the age at first sexual experience, and the number of lifetime partners,
14 individuals from Group 1 and four from Group 4 who had not sexual
experience were excluded from the statistical analysis of these
categories. Among the 1,043 individuals evaluated, the self-reports
demonstrated the predominance of heterosexual behaviour in the Groups
1, 2, 3, and 4 (97.5%, 91.8%, 75.2%, and 83.7%, respectively). The
HIV-1 exposed but uninfected individuals showed the highest rate of
heterosexual behavior (p < 0.0001).
The results of other sexual behaviors evaluated such as age at first
sexual experience, number of lifetime partners and the occurrence of
previous STDs (Table 3), were significantly different for all of these
variables (p < 0.0001). Age at first sexual experience before 15 years
was reported by 42.9% and 42.4% of the individuals from groups 3
and 4, respectively; the HIV-1-infected asymptomatic individuals and
patients with AIDS reported the highest number of lifetime partners (p
< 0.0001) and more previous STDs (p < 0.0001). Of the STDs
mentioned, the patients with AIDS reported the highest rates of
gonorrhoea (20.1%, p < 0.0001), syphilis (10.7%, p < 0.0001),
condyloma (9.4%, p = 0.0017), and genital herpes (3.2%, p = 0.0293)
compared to the other groups.
Serological results: Table 4 shows the seropositivity for other
infections that share the same route of HIV-1 transmission. The Group
1 was excluded from the statistical analysis to compare the results of
the seropositivity with the other groups, because they have all been
screened and were negative to the serological tests evaluated in this
study.
The patients with AIDS showed the highest rates of reactivity for
syphilis, with values of 6.3% when assessed by VDRL (p = 0.1133)
and 25.6% when assessed by ELISA (p = 0.0010). For the HBV
serological markers evaluated, the HIV-1 infected asymptomatic and
AIDS patients showed higher reactivity to HBsAg (3.3% and 3.8%,
respectively) and to anti-HBc (36.5% and 37.4%, respectively) than
the HIV-1 exposed but uninfected individuals. However, the difference
of reactivity was not significant. As regards anti-HCV antibodies, the
difference was significant. HIV-1-infected patients showed higher rates,
with 16.0% of reactivity among the asymptomatic cases and 22.3%
among the AIDS cases than the HIV-1 exposed but uninfected
individuals (p < 0.0001).
Table 5 shows the positivity for HTLV I/II infection. The rates of
seropositivity were higher among the HIV-1 infected asymptomatic
and AIDS patients than HIV-1 exposed but uninfected individuals when
the screening serological tests of ELISA were considered (p = 0.0368
for ELISA with lysate and recombinant antigens, and p = 0.0066 for
Table 2
Risk factors associated with HIV-1 infection in healthy individuals, HIV-1 exposed but uninfected individuals, HIV-1-infected asymptomatic, and patients with
AIDS, from Londrina and region, south of Brazil, October 2001 to December 2003.
Risk factors Group 1 Group 2 Group 3 Group 4 Total
No. (%) No. (%) No. (%) No. (%) No. (%)
Route of infection a
Sexual 0 (0) 130 (88.4) 140 (87.0) 506 (82.0) 776 (83.7)
Other§ 2 (100.0) 17 (11.6) 21 (13.0) 111 (18.0) 151 (16.3)
IVDUb
Yes 0 (0) 3 (2.0) 17 (10.6) 85 (13.8) 105 (9.9)
No 136 (100.0) 144 (98.0) 144 (89.4) 532 (86.2) 956 (90.1)
Hemophiliac
Yes 0 (0) 0 (0) 2 (1.2) 5 (0.8) 7 (0.7)
No 136 (100.0) 147 (100.0) 159 (98.8) 612 (99.2) 1054 (99.3)
Blood transfusiond
Yes 2 (1.5) 13 (8.8) 5 (3.1) 29 (4.7) 49 (4.6)
No 134 (98.5) 134 (91.2) 156 (96.9) 584 (95.3) 1008 (95.4)
Sexual behavior e
Heterosexual 119 (87.5) 135 (91.8) 121 (75.1) 513 (83.1) 888 (83.7)
Men who have sex 3 (2.5) 12 (8.2) 40 (24.8) 100 (16.3) 155 (14.9)
with men
Group 1: 136 healthy individuals; Group 2: 147 HIV-1 exposed but uninfected individuals; Group 3: 161 HIV-1-infected asymptomatic patients with CD4 T cell counts
≥ 350 cells/mm3 ; Group 4: 617 HIV-1 infected patients with symptoms of the disease and/or CD4 T cell counts < 350 cells/mm3. §: Group 1: blood transfusion (n = 2);
Group 2: sexual and blood exposures (n = 17); Group 3: sexual and blood exposures (n = 10); blood exposure (n = 9); accident with blood (n = 2); Group 4: sexual and
blood exposures (n = 36); blood exposure (n = 68); accident with blood (n = 2); tattoo (n = 3); mother-to-child transmission (n = 2). a: Fisher exact test, p < 0.0001. b:
intravenous drug use (IVDU): Chi-square test, χ2: 35.6064, p < 0.0001; c: Fisher exact test, p = 0.5154; d: Chi-square test, χ2: 9.8345; p = 0.0200; e: 18 individuals
without sexual activity were excluded (Group 1, n = 14; Group 4, n = 4). Chi-square test, χ2: 37.1856; p < 0.0001.
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Table 3
Risk factors associated with sexual transmission of HIV-1 infection in healthy individuals, HIV-1 exposed but uninfected individuals, HIV-1-infected asymptomatic,
and patients with AIDS, from Londrina and region, south of Brazil, October 2001 to December 2003
Risk factors Group 1 Group 2 Group 3 Group 4 Total
No. (%) No. (%) No. (%) No. (%) No. (%)
Age at first sexa
after age 15 26 (21.3) 47 (32.0) 69 (42.9) 260 (42.1) 402 (37.9)
before age 15 96 (78.7) 100 (68.0) 92 (57.1) 353 (57.2) 641 (61.5)
Number of lifetime partnersb
1 41 (33.6) 45 (30.6) 19 (11.9) 38 (6.3) 143 (13.8)
2 -10 58 (47.5) 64 (43.5) 74 (46.6) 302 (49.6) 498 (48.1)
> 10 23 (18.9) 38 (25.9) 66 (41.5) 268 (44.1) 395 (38.1)
Previous DSTc
Yes 4 (3.0) 30 (20.4) 52 (32.5) 233 (38.1) 319 (30.2)
No 132 (97.0) 117 (79.6) 108 (67.5) 379 (61.9) 736 (69.8)
Previous DST
Gonorrhoead 3 (2.2) 15 (10.20) 27 (16.8) 124 (20.1) 169 (15.9)
Syphilise. 1 (0.7) 3 (2.0) 13 (8.1) 66 (10.7) 83 (7.8)
Genital Herpesf 0 (0) 5 (3.4) 1 (0.6) 20 (3.2) 26 (2.4)
Condylomag 1 (0.7) 7 (4.8) 9 (5.6) 58 (9.4) 75 (7.1)
Group 1: 136 healthy individuals; Group 2: 147 HIV-1 exposed but uninfected individuals; Group 3: 161 HIV-1-infected asymptomatic patients with CD4 T cell counts
≥ 350 cells/mm3 ; Group 4: 617 HIV-1 infected patients with symptoms of the disease and/or CD4 T cell counts < 350 cells/mm3; a: 18 individuals without sexual activity
were excluded (Group 1, n = 14; Group 4, n = 4). Chi-square test, χ2: 23.56; p < 0.0001; b: 18 individuals without sexual activity were excluded (Group 1, n = 14; Group
4, n = 4). Chi-square test, χ2: 23.56; p < 0.0001; c: Chi-square test, χ2: 72.97, p < 0.0001; d: Chi-square test, χ2: 30.81, p < 0.0001; e: Chi-square test, χ2: 23.37, p <
0.0001; f: Fisher Exact Test, p = 0.0293; g: Chi-square test, χ2: 15.13, p = 0.0017.
Table 4
Seropositivity to syphilis, hepatitis B virus and hepatitis C virus infections in healthy individuals, HIV-1 exposed but uninfected individuals, HIV-1 infected
asymptomatic, and patients with AIDS, from Londrina and region, south of Brazil, October 2001 to December 2003
Serological result Group 1* Group 2 Group 3 Group 4 Total
No. (%) No. (%) No. (%) No. (%) No. (%)
VDRLa
Positive 0 (0) 6 (4.1) 4 (2.5) 39 (6.3) 49 (4.6)
Negative 136 (100) 141 (95.9) 152 (94.4) 561 (90.9) 990 (93.3)
ELISA Tp IgGb
Positive 1 (0.7) 18 (12.2) 30 (18.6) 158 (25.6) 207 (19.5)
Negative 135 (99.3) 124 (84.3) 126 (78.3) 451 (73.1) 836 (78.8)
HBsAgc
Positive 0 (0) 2 (1.4) 6 (3.8) 20 (3.3) 28 (2.7)
Negative 136 (100) 145 (98.6) 150 (96.2) 581 (96.7) 1012 (97.3)
Anti-HBcd
Positive 0 (0) 40 (27.2) 57 (36.5) 225 (37.4) 322 (31.0)
Negative 136 (100) 107 (72.8) 99 (63.5) 376 (62.6) 718 (69.0)
Anti-HCVe
Positive 0 (0) 6 (4.1) 25 (16.0) 134 (22.3) 165 (15.9)
Negative 136 (100) 141 (95.9) 131 (84.0) 467 (77.7) 875 (84.1)
Group 1: 136 healthy individuals; Group 2: 147 HIV-1 exposed but uninfected individuals; Group 3: 161 HIV-1-infected asymptomatic patients and CD4 T cells ≥ 350
cells/mm3; Group 4: 617 HIV-1 infected patients with symptoms of the disease and/or CD4 T cells < 350 cells/mm3. * The Group 1 was excluded for the statistical
analysis to compare the seropositivity obtained on the tests. a: Venereal Disease Research Laboratories. Chi-square test. χ2 4.36. degree of freedom: 2. p = 0.1133. b:
Enzyme-linked immunosorbent assay for specific IgG for Treponema pallidum. Chi-square test χ2: 12.85. degree of freedom: 2, p = 0.0010. c: Hepatitis B surface
antigen. Exact Fisher test. p = 0.4088; d: Antibody against the core antigen of hepatitis B virus. Chi square test χ2: 5.46, degree of freedom: 2, p = 0.0653. e: Antibody
to hepatitis C virus. Chi-square test χ2: 26.89, degree of freedom: 2, p < 0.0001.
ELISA with viral synthetic peptides and recombinant antigens). When
the results were evaluated by the confirmatory results, the patients
with AIDS showed the highest rates of HTLV I/II infection (6.3%),
followed by HIV-1-infected asymptomatic (2.5%) and HIV-1-exposed
but uninfected (0.7%) individuals. However, the difference was not
significant among the groups 2, 3, and 4 when the confirmatory tests
were considered (p = 0.2529).
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DISCUSSION
Brazil is one of the countries with the greatest number of AIDS cases
in the world. Lately, small counties are experiencing relatively high
incidence rates when compared to large urban centers. The results obtained
in this study confirm the data reported by the Brazilian Ministry of Health
and other researches showing the spread of the epidemic from the major
urban centers to smaller municipalities across most of Paraná State,
southern Brazil, the predominance of the sexual route of transmission,
with mainly heterosexual unprotected intercourse, the increased number
of HIV/AIDS in women, the increased number of HIV/AIDS among both
younger and older individuals, and the predominance of individuals with
incomplete basic schooling11,26. Although all the main modes of
transmission coexist in the southern Brazilian region assessed, with
significant levels of risky behavior such as early sexual activity, unprotected
sex with multiple partners and the use of contaminated drug-injection
equipment, the HIV-1 transmission patterns are changing in the region
assessed in this study. The results showed the lower rates of transmission
through blood and blood products and of HIV-1 infection associated with
injectable drug use at this time in this region. Some factors could explain
these results, such as the intrinsic transfusional system and its improvement
revealed by the quality of the hemotherapy services carried out in our
country and by the prevention programs, including efforts to extend
coverage for harm reduction projects. The Ministry of Health, as part of
the federal government, politically supports all of these projects and
financially supports the majority as well34.
The results showing the predominance of HIV-1-infected
asymptomatic patients and AIDS cases among the individuals with
low educational levels and worst economic conditions compared with
the HIV-1-uninfected individuals confirmed previous studies
emphasizing the connection between vulnerability to HIV-1 infection
and social inequalities4,7,19,26. The high prevalence of HIV-1 infection
among individuals who only attended primary school or who failed to
complete secondary school confirms that the education is a key defense
against the spread of HIV.
Taken together, these data confirmed the major features of the HIV/
AIDS epidemic in Brazil, i.e., the steady decrease in the male to female
ratio as a result of an increasing proportion of female patients, fueled
by heterosexual transmission, and the fact that patients are from the
poorer part of society and live farther away from urban centers.
The predominance of patients with AIDS among the HIV-1-infected
patients enrolled in this study may reflect the delay in HIV-1 diagnosis
and in the access to specialized STDs centers for this population. It
may also indicate that this is a population with more time of exposure
to the risk factor associated with HIV-1 acquisition.
The self-reports of lower previous STDs and lower lifetime number
of sex partners among the faithful blood donors are in agreement with
the idea that repeat and altruistic blood donors are safer then
replacement donors, and have a lower risk of infectious diseases. This
result justifies the concerted efforts in the past years to change the
blood donor supply from “replacement” first-time donors to repeat
“altruistic” donors in Brazil.
The self-reports of more previous STDs infections, higher lifetime
number of sex partners, earlier first sexual experience in the HIV-1-
infected asymptomatic individuals and in patients with AIDS compared
to the healthy individuals and HIV-1 exposed but uninfected individuals
confirmed previous studies from different parts of the world which
found that high-risk sexual behaviour and STDs play a role in enhancing
the transmission of HIV-1 by increasing the susceptibility of non-HIV-
1-infected individuals and the infectiousness of HIV-1-infected
individuals1,2,13,14. Although HIV-1 transmission across intact mucosal
surfaces can occur, surface abrasions and breaks in the integrity of the
mucosal epithelium increase the risk of HIV-1 infection. STDs and
other factors amplifying inflammatory T cell populations in regional
mucosal sites also exacerbate HIV-1 transmission45. The higher
seropositivity to the treponemal test for syphilis, to HBV, HCV and
HTLV I/II infections in patients with AIDS compared to the HIV-1
exposed but uninfected individuals confirmed the strong association
Table 5
Results of the human T lymphocyte virus type I and I (HTLV I/II) infection, obtained by the serological screening and confirmatory tests, in healthy individuals.
HIV-1 exposed but uninfected individuals, HIV-1-infected asymptomatic, and patients with AIDS, from Londrina and region, south of Brazil, October 2001 to
December 2003
Result Group 1* Group 2 Group 3 Group 4 Total
No. (%) No. (%) No. (%) No. (%) No. (%)
Anti-HTLV I/II a
Positive 0 (0) 2 (1.4) 6 (3.7) 38 (6.2) 46 (4.3)
Negative 136 (100) 145 (98.6) 150 (93.2) 564 (91.4) 995 (93.8)
Anti-HTLV I/II b
Positive 0 (0) 1 (0.7) 6 (3.7) 42 (6.8) 49 (4.6)
Negative 136 (100) 146 (99.3) 150 (93.2) 560 (90.8) 992 (93.5)
WB and/or PCRc
Positive 0 (0) 1 (0.7) 4 (2.5) 39 (6.3) 44 (4.1)
Negative 0 (0) 0 (0) 2 (1.2) 4 (0.6) 6 (0.6)
Group 1: 136 healthy individuals; Group 2: 147 HIV-1-exposed but uninfected individuals; Group 3:161 HIV-1-infected asymptomatic patients with CD4 T cell counts
≥ 350 cells/mm3 ; Group 4: 617 HIV-1 infected patients with symptoms of the disease and/or CD4 T cell counts < 350 cells/mm3. * The Group 1 was excluded for the
statistical analysis to compare the seropositivity obtained on the tests. a: Enzyme-linked immunosorbent assay with viral lysates and recombinant antigens. Chi-square
test χ2: 6.60, degree of freedom: 2 p = 0.0368. b: Enzyme-linked immunosorbent assay with viral synthetic peptides and recombinant antigens Chi-square test χ2: 10.05,
degree of freedom: 2, p = 0.0066. c: Western Blot and/or Polymerase Chain Reaction. Exact Fisher test, p = 0.2529.
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between past/current syphilis and HIV-1 infection emphasizing the
important role played by syphilis in the spread of HIV-1 infection,
most likely as a co-factor of HIV-1 transmission, had already been
identified in previous studies1,2,46. The presence of concomitant STDs
at the time of HIV-1 inoculation is associated with increased risk for
infection and increased progression, which may be due to inflammation,
ulceration, and breakdown in local barriers but also to nonspecific
systemic inflammation and release of cytokines that produce systemic
immune activation25,37,40,43,46. Alternatively, greater sexual activity could
increase the hazard of exposure to a more virulent HIV-1 strain37.
As regards syphilis, the infection with Treponema pallidum was
assessed by a nontreponemal serological test (VDRL) and a treponemal
serological test (ELISA) and therefore individuals with positive syphilis
serology included recently infected individuals, as well as men and
women with old and/or untreated infections. This may explain the
increase observed in the rates of syphilis seropositivity when assessed
by ELISA in all groups.
The rates of seropositivity obtained for other infections that share
the same route of the HIV-1 transmission may reflect the life style of
the population assessed. The highest levels of seropositivity for syphilis,
HBV, HCV and HTLV I/II infections in the HIV-1-infected patients
was expected and confirmed the overlapping of the routes of
transmission of these microorganisms. The high seropositivity to these
serological markers in HIV-1 patients was also reported in previous
studies carried out on Brazil22,33,41. In addition, co-infections such as
HCV infection20,29,38 and HTLV I/II infection3,6,28 have been reported to
be risk factors for HIV-1 infection and disease progression.
The pathogenic mechanisms of HIV-1 infection are multifactorial
and the effect of a given factor on the risk to acquire and/or to delay
the disease progression will be relative. However, the results obtained
in the present study may be useful in documenting the predominant
socio-demographic and epidemiological characteristics for HIV-1
infection among the residents of Londrina and region of Paraná State,
located in southern Brazil. We hope that these data will contribute to
the improvement of the current HIV-1 prevention, monitoring and
therapeutic programs targeted at this population.
RESUMO
Características sociodemográficas e epidemiológicas associadas
com a infecção pelo vírus da imunodeficiência humana tipo 1
(HIV-1) em indivíduos expostos ao HIV-1 mas não infectados e
em pacientes infectados pelo HIV-1, provenientes da população
da região Sul do Brasil
Este estudo transversal descreve as principais características
sociodemográficas e epidemiológicas associadas com a infecção pelo
HIV-1 em 1.061 indivíduos atendidos em Londrina e região, Sul do
Brasil: 136 indivíduos saudáveis (Grupo 1), 147 indivíduos expostos
ao HIV-1 mas não infectados (Grupo 2), 161 pacientes infectados pelo
HIV-1 assintomáticos (Grupo 3) e 617 pacientes com aids (Grupo 4).
Os dados foram obtidos pela aplicação de um questionário padronizado
e realização de testes sorológicos. A idade dos indivíduos variou de
15,1 a 79,5 anos; 54,0% e 56,1% dos pacientes dos Grupos 3 e 4,
respectivamente, eram homens. As principais características dos
indivíduos dos Grupos 2, 3 e 4 foram o predomínio do nível educacional
com até oito anos de escolaridade (58,8%, 60,2% e 62,4%,
respectivamente), a via sexual de transmissão (88,4%, 87,0% e 82,0%,
respectivamente), o comportamento heterossexual (91,8%, 75,2% e
83,7%, respectivamente) e antecedentes de doenças sexualmente
transmissíveis (20,4%, 32,5% e 38,1%, respectivamente). Os pacientes
com aids apresentaram os valores mais elevados de soropositividade
para sífilis (25,6%), anti-HCV (22,3%) e anti-HTLV I/II em dois testes
de triagem sorológica (6,2% e 6,8%, respectivamente). Os resultados
documentando as características predominantes associadas com a
infecção pelo HIV-1 observada nos indivíduos de Londrina e região,
poderá ser útil na melhoria dos atuais programas de prevenção,
monitoramento e de tratamento da infecção pelo HIV-1 dirigidos a
esta população.
ACKNOWLEDGMENTS
We thank the Health Ministry - Brazilian National Sexual
Transmitted Disease/AIDS Program (CN-DST/AIDS), for their
financial support with the cooperative agreement of the State University
of Londrina (Grants UNESCO-UEL CFA 667/01), the Londrina
University Hospital for technical and administrative support, and the
PIBIC CNPq Program for the student grant.
REFERENCES
1. AKLILU, M.; MESSELE, T.; TSEGAYE, A. et al. - Factors associated with HIV-1
infection among sex workers of Addis Ababa, Ethiopia. AIDS, 15: 87-96, 2001.
2. ALARCON, J.O.; JOHNSON, K.M.; COURTOIS, B. et al. - Determinants and prevalence
of HIV infection in pregnant Peruvian women. AIDS, 17: 613-618, 2003.
3. ARAI, M.; OHASHI, T.; TSUKAHARA, T. et al. - Human T-cell leukemia virus type 1
Tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF.
Virology, 241: 298-303, 1998.
4. BARBOSA, L.M. - Profiles of social vulnerability to the infection by HIV of the
populations of Northeast Brazilians. In: SIMPÓSIO BRASILEIRO DE PESQUISA
EM HIV/AIDS, 5., Rio de Janeiro. 2003. Resumos. p. 33.
5. BARCELLINI, W.; RIZZARDI, G.P.; VELATI, C. et al. - In vitro production of type 1
and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-
negative intravenous drug users. AIDS, 9: 691-694, 1995.
6. BARTHOMOLEW, C.; BLATTNER, W. & CLEGHORN, F. - Progression to AIDS in
homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet, 2: 1469,
1987.
7. BATES, I.; FENTON, C.; GRUBER, J. et al. - Vulnerability to malaria, tuberculosis, and
HIV/AIDS infection and disease. Part 1: determinants operating at individual and
household level. Lancet, 4: 267-277, 2004.
8. BRASIL. ASSOCIAÇÃO NACIONAL DE EMPRESAS DE PESQUISA (ANEP) -
Critérios de classificação econômica Brasil. URL: http://www.anep.org.br. Captured
in 05/11/2000.
9. BRASIL. Ministério da Saúde. Secretaria de Políticas de Saúde. Coordenação Nacional
de DST e AIDS - Revisão da definição nacional de caso de AIDS em indivíduos
com 13 anos ou mais, para fins de vigilância epidemiológica. Brasília, Ministério
da Saúde, 1998.
10. BRASIL. Ministério da Saúde. Agência Nacional de Vigilância Sanitária - Portaria no.
488 de 17 de junho de 1998.
246
REICHE, E.M.V.; BONAMETTI, A.M.; WATANABE, M.A.E.; MORIMOTO, H.K.; MORIMOTO, A.A.; WIECHMANN, S.L.; BREGANÓ, J.W.; MATSUO, T. & REICHE, F.V. - Socio-
demographic and epidemiological characteristics associated with human immunodeficiency virus type 1 (HIV-1) infection in HIV-1-exposed but uninfected individuals, and in HIV-1-
infected patients from a southern Brazilian population. Rev. Inst. Med. trop. S. Paulo, 47(5): 239-246, 2005.
11. BRASIL. Ministério da Saúde. Coordenação de DST e AIDS - 01 à 52 semanas
epidemiológicas janeiro a dezembro de 2003. Bol. Epidem.AIDS, 17(1), 2003.
12. BRASIL. Ministério da Saúde - Recomendações para terapia anti-retroviral em
adultos e adolescentes infectados pelo HIV 2002/2003. Brasília, 2002. URL: http:/
/www.aidsw.gov.br. Captured in 27/12/2002.
13. BUVÉ, A.; WEISS, H.A.; LAGA, M. et al. - The epidemiology of trichomoniasis in
women in four African cities. AIDS, 5 (suppl. 4): S89-S96, 2001.
14. BUVÉ, A.; WEISS, H.A.; LAGA, M. et al. - The epidemiology of gonorrhoea, chlamydial
infection and syphilis in four African cities. AIDS, 15 (suppl. 4 ): S79-S88, 2001.
15. CAIAFFA, W.T.; PROIETTI, F.A.; CARNEIRO-PROIETTI, A.B. et al. - The dynamics
of the human immunodeficiency virus epidemics in the south of Brazil: increasing
role of injection drug users. Clin. infect. Dis., 37 (suppl. 5): S376-S381, 2003.
16. CENTERS FOR DISEASE CONTROL AND PREVENTION - Revised guidelines for
HIV counseling, testing, and referral and revised recommendations for HIV screening
of pregnant women. M.M.W.R., 50 (RR-19): 8-9, 2001.
17. CLERICI, M.; GIORGI, J.V.; CHOU, C.C. et al. - Cell-mediated immune response to
human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with
recent sexual exposure to HIV-1. J. infect. Dis., 165: 1012-1019, 1992.
18. DEAN, A.G.; DEAN, J.Á.; COULOMBIER, D. et al. - World-processing database,
and statistics program for public health on IBM-compatible microcomputers.
Atlanta, Centers for Disease Control and Prevention, 1995.
19. DHALIA, C.; BARREIRA, D. & CASTILHO, E.A. - A aids no Brasil. Situação atual e
tendências. Bol. Epidem. AIDS, 17 (1): 3-13, 2000.
20. DORRUCCI, M.; PEZZOTTI, P.; PHILLIPS, A.N.; LEPRI, A.C. & REZZA, G. - Co-
infection of hepatitis C virus with human immunodeficiency virus and progression
to AIDS. Italian Seroconversion Study. J. infect. Dis., 172: 1503-1508, 1995.
21. DUNN, O.J. - Multiple comparisons using rank sums. Technometrics, 6: 241-252, 1964.
22. ETZEL, A.; SHIBATA, G.Y.; ROZMAN, M. et al. - HTLV-1 and HTLV-2 infections in
HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors. J.
AIDS hum. Retrov., 26: 185-190, 2001.
23. EVANS, D.T. & DESROSIERS, R.C. - Immune evasion strategies of the primate
lentiviruses. Immunol. Rev., 183: 141-158, 2001.
24. FAUCI, A.S.; PANTALEO, G.; STANLEY, S. & WEISSMAN, D. - Immunopathogenic
mechanisms of HIV infection. Ann. intern. Med., 124: 654-663, 1996.
25. FLEMING, D.T. & WASSERHEIT, J.N. - From epidemiological synergy to public health
policy and practice: the contribution of other sexually transmitted diseases to sexual
transmission of HIV infection. Sex. transm. Infect., 75: 3-17, 1999.
26. FONSECA, M.G.; SZWARCWALD, C.L. & BASTOS, F.I. - Análise sociodemográfica
da epidemia de aids no Brasil, 1989-1997. Rev. Saúde públ. (S. Paulo), 36: 678-
685, 2002.
27. FOWKE, K.R.; NAGELKERKE, N.J.; KIMANI, J. et al. - Resistance to HIV-1 infection
among persistently seronegative prostitutes in Nairobi, Kenya. Lancet, 348: 1347-
1351, 1996.
28. GREENE, W.C.; BOHNLEIN, E. & BALLARD, D.W. - HIV-1, HTLV-I and normal T-
cell growth: transcriptional strategies and surprises. Immunol. today, 10: 272-278,
1989.
29. GREUB, G.; LEDERGERBER, B.; BATTEGAY, M. et al. - Clinical progression, survival,
and immune recovery during antiretroviral therapy in patients with HIV-1 and
hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet, 356: 1800-1805,
2000.
30. HOGAN, C. & HAMMER, S.M. - Host determinants in HIV infection and disease. Part
1. Cellular and humoral immune responses. Ann. intern. Med., 134: 761-776, 2001.
31. HOGAN, C. & HAMMER, S.M. - Host determinants in HIV infection and disease. Part
2. Genetic factors and implications for antiretroviral therapeutics. Ann. intern. Med.,
134: 978-996, 2001.
32. LIFSON, A.R.; BUCHBINDER, S.P.; SHEPPARD, H.W. et al. - Long-term human
immunodeficiency virus infection in asymptomatic homosexual and bisexual men
with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.
J. infect. Dis., 163: 959-965, 1991.
33. MENDES-CORRÊA, M.C.; BARONE, A.A. & GUASTINI, C. - Hepatitis C virus
seroprevalence and risk factors among patients with HIV infection. Rev. Inst. Med.
trop. S. Paulo, 43: 15-19, 2001.
34. MESQUITA, F.; DONEDA, D.; GANDOLFI, D. et al. - Brazilian response to the human
immunodeficiency virus/acquired immunodeficiency syndrome epidemic among
infection drug users. Clin. infec. Dis., 37 (suppl. 5): S383-S385, 2003.
35. MORIMOTO, H.K. - Infecção pelos vírus linfotrópicos de células T humanas dos
tipos I (HTLV I) e II (HTLV II) em indivíduos infectados pelo vírus da
imunodeficiência humana (HIV) em Londrina e região, Paraná. São Paulo, 2003.
(Dissertação de Mestrado - Faculdade de Ciências Farmacêuticas da Universidade
de São Paulo).
36. PANTALEO, G.; GRAZIOSI, C.; DEMAREST, J.F. et al . - HIV infection is active and
progressive in lymphoid tissue during the clinically latent stage of disease. Nature,
362: 355-358, 1993.
37. PHAIR, J.; JACOBSON, L.; DETELS, R. et al. - Acquired immune deficiency syndrome
occurring within 5 years of infection with human immunodeficiency virus type-1: the
Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr., 5: 490-496, 1992.
38. PIROTH, L.; GRAPPIN, M.; CUZIN, L. et al. - Hepatitis C virus co-infection is a negative
prognostic factor for clinical evolution in human immunodeficiency virus-positive
patients. J. viral Hepatitis, 7: 302-308, 2000.
39. PLUMMER, F.A.; BALL, T.B.; KIMANI, J. & FOWKE, K.R. - Resistance to HIV-1
infection among highly exposed sex workers in Nairobi: what mediates protection
and why does it develop? Immunol. Lett., 66: 27-34, 1999.
40. PLUMMER, F.A. - Heterosexual transmission of human immunodeficiency virus type 1
(HIV-1): interactions of conventional sexually transmitted diseases, hormonal
contraception and HIV-1. AIDS Res. Hum. Retroviruses, 14 (suppl. 1): S5-S10, 1998.
41. REICHE, E.M.; VOGLER, I.H.; MORIMOTO, H.K. et al. - Evaluation of surrogate
markers for human immunodeficiency virus infection among blood donors at the
blood bank of Hospital Universitário Regional Norte do Paraná, Londrina, PR, Brazil.
Rev. Inst. Med. trop. S. Paulo, 45: 23-27, 2003.
42. ROSENBERG, Z.F. & FAUCI, A.S. - Immunopathogenesis of HIV infection. FASEB J.,
5: 2382-2390, 1991.
43. ROYCE, R.A.; SENA, A.; CATES Jr., W. & COHEN, M.S. - Sexual transmission of HIV.
New Engl. J. Med., 336: 1072-1078, 1997.
44. SAS - SAS/STAT user’s guide, Version 6. 4. ed., Cary, SAS Institute, 1989.
45. WAHL, S.M.; SMITH, P.D. & JANOFF, E.N. - Human immunodeficiency virus type 1
infection, mucosal immunity, and pathogenesis: comments and conference summary.
J. infect. Dis., 179 (suppl. 3): S397-S400, 1999.
46. WASSERHEIT, J.N. - Epidemiological synergy: interrelationships between human
immunodeficiency virus infection and other sexually transmitted diseases. Sex.
transm. Dis., 19: 61-77, 1992.
Received: 27 April 2005
Accepted: 27 July 2005
